AKT	B:C0164786
/	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
Signaling	O
in	O
Glioblastoma	O
.	O

AKT	O
/	O
glycogen	B:C0244988
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
Signaling	O
in	O
Glioblastoma	O
.	O

AKT	O
/	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
Signaling	B:C0037080
in	O
Glioblastoma	O
.	O

AKT	O
/	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
Signaling	O
in	O
Glioblastoma	B:C0017636
.	O

Glioblastoma	B:C0017636
(	O
Glioblastoma	O
)	O
is	O
the	O
most	O
aggressive	O
of	O
primary	O
brain	O
tumors	I:C0006118
.	O

Glioblastoma	O
(	O
Glioblastoma	B:C0017636
)	O
is	O
the	O
most	O
aggressive	O
of	O
primary	O
brain	O
tumors	I:C0006118
.	O

Glioblastoma	O
(	O
Glioblastoma	O
)	O
is	O
the	O
most	O
aggressive	O
of	O
primary	O
brain	B:C0006118
tumors	I:C0006118
.	O

Despite	O
the	O
progress	O
in	O
understanding	O
the	O
biology	B:C0005532
of	O
the	O
pathogenesis	O
of	O
glioma	O
made	O
during	O
the	O
past	O
decade	O
,	O
the	O
clinical	O
outcome	I:C0456984
of	O
patients	O
with	O
Glioblastoma	O
remains	O
still	O
poor	O
.	O

Despite	O
the	O
progress	O
in	O
understanding	O
the	O
biology	O
of	O
the	O
pathogenesis	B:C0699748
of	O
glioma	O
made	O
during	O
the	O
past	O
decade	O
,	O
the	O
clinical	O
outcome	I:C0456984
of	O
patients	O
with	O
Glioblastoma	O
remains	O
still	O
poor	O
.	O

Despite	O
the	O
progress	O
in	O
understanding	O
the	O
biology	O
of	O
the	O
pathogenesis	O
of	O
glioma	B:C0017638
made	O
during	O
the	O
past	O
decade	O
,	O
the	O
clinical	O
outcome	I:C0456984
of	O
patients	O
with	O
Glioblastoma	O
remains	O
still	O
poor	O
.	O

Despite	O
the	O
progress	O
in	O
understanding	O
the	O
biology	O
of	O
the	O
pathogenesis	O
of	O
glioma	O
made	O
during	O
the	O
past	O
decade	O
,	O
the	O
clinical	B:C0456984
outcome	I:C0456984
of	O
patients	O
with	O
Glioblastoma	O
remains	O
still	O
poor	O
.	O

Despite	O
the	O
progress	O
in	O
understanding	O
the	O
biology	O
of	O
the	O
pathogenesis	O
of	O
glioma	O
made	O
during	O
the	O
past	O
decade	O
,	O
the	O
clinical	O
outcome	I:C0456984
of	O
patients	O
with	O
Glioblastoma	B:C0017636
remains	O
still	O
poor	O
.	O

Deregulation	O
of	O
many	O
signaling	B:C0037080
pathways	I:C0037080
involved	O
in	O
growth	O
,	O
survival	O
,	O
migration	O
and	O
resistance	O
to	O
treatment	O
has	O
been	O
implicated	O
in	O
pathogenesis	O
of	O
Glioblastoma	O
.	O

Deregulation	O
of	O
many	O
signaling	O
pathways	I:C0037080
involved	O
in	O
growth	B:C1516170
,	O
survival	O
,	O
migration	O
and	O
resistance	O
to	O
treatment	O
has	O
been	O
implicated	O
in	O
pathogenesis	O
of	O
Glioblastoma	O
.	O

Deregulation	O
of	O
many	O
signaling	O
pathways	I:C0037080
involved	O
in	O
growth	O
,	O
survival	O
,	O
migration	B:C0027627
and	O
resistance	O
to	O
treatment	O
has	O
been	O
implicated	O
in	O
pathogenesis	O
of	O
Glioblastoma	O
.	O

Deregulation	O
of	O
many	O
signaling	O
pathways	I:C0037080
involved	O
in	O
growth	O
,	O
survival	O
,	O
migration	O
and	O
resistance	O
to	O
treatment	B:C0087111
has	O
been	O
implicated	O
in	O
pathogenesis	O
of	O
Glioblastoma	O
.	O

Deregulation	O
of	O
many	O
signaling	O
pathways	I:C0037080
involved	O
in	O
growth	O
,	O
survival	O
,	O
migration	O
and	O
resistance	O
to	O
treatment	O
has	O
been	O
implicated	O
in	O
pathogenesis	B:C0699748
of	O
Glioblastoma	O
.	O

Deregulation	O
of	O
many	O
signaling	O
pathways	I:C0037080
involved	O
in	O
growth	O
,	O
survival	O
,	O
migration	O
and	O
resistance	O
to	O
treatment	O
has	O
been	O
implicated	O
in	O
pathogenesis	O
of	O
Glioblastoma	B:C0017636
.	O

One	O
of	O
these	O
pathways	B:C0037080
is	O
phosphatidylinositol	O
-	O
3	O
kinases	O
(	O
PI3K	O
)	O
/	O
protein	O
kinase	O
B	O
(	O
AKT	O
)	O
/	O
rapamycin	O
-	I:C1515673
sensitive	I:C1515673
mTOR	I:C1515673
-	I:C1515673
complex	I:C1515673
(	I:C1515673
mTOR	I:C1515673
)	I:C1515673
pathway	I:C1515673
,	O
intensively	O
studied	O
and	O
widely	O
described	O
so	O
far	O
.	O

One	O
of	O
these	O
pathways	O
is	O
phosphatidylinositol	O
-	O
3	O
kinases	O
(	O
PI3K	O
)	O
/	O
protein	O
kinase	O
B	O
(	O
AKT	O
)	O
/	O
rapamycin	B:C1515673
-	I:C1515673
sensitive	I:C1515673
mTOR	I:C1515673
-	I:C1515673
complex	I:C1515673
(	I:C1515673
mTOR	I:C1515673
)	I:C1515673
pathway	I:C1515673
,	O
intensively	O
studied	O
and	O
widely	O
described	O
so	O
far	O
.	O

Much	O
less	O
attention	O
has	O
been	O
paid	O
to	O
the	O
role	O
of	O
glycogen	B:C0244988
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
(	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
)	O
,	O
a	O
target	O
of	O
AKT	O
.	O

Much	O
less	O
attention	O
has	O
been	O
paid	O
to	O
the	O
role	O
of	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
(	O
glycogen	B:C0244988
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
)	O
,	O
a	O
target	O
of	O
AKT	O
.	O

Much	O
less	O
attention	O
has	O
been	O
paid	O
to	O
the	O
role	O
of	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
(	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
)	O
,	O
a	O
target	O
of	O
AKT	B:C0164786
.	O

In	O
this	O
review	O
we	O
focus	O
on	O
the	O
function	O
of	O
AKT	B:C0164786
/	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
signaling	O
in	O
Glioblastoma	O
.	O

In	O
this	O
review	O
we	O
focus	O
on	O
the	O
function	O
of	O
AKT	O
/	O
glycogen	B:C0244988
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
signaling	O
in	O
Glioblastoma	O
.	O

In	O
this	O
review	O
we	O
focus	O
on	O
the	O
function	O
of	O
AKT	O
/	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
signaling	B:C0037080
in	O
Glioblastoma	O
.	O

In	O
this	O
review	O
we	O
focus	O
on	O
the	O
function	O
of	O
AKT	O
/	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
3	I:C0244988
β	I:C0244988
signaling	O
in	O
Glioblastoma	B:C0017636
.	O

